Cutera, Inc. (CUTR) Research

Cutera, Inc. is a medical technology enterprise specializing in the research, development, manufacturing, marketing, and servicing of cutting-edge laser and energy-based aesthetic systems for medical professionals worldwide. The company's comprehensive product line includes several advanced devices: Secret PRO, an innovative system combining fractional CO2 technology for thorough skin resurfacing with radio frequency (RF) microneedling for deep dermal tissue restructuring. truSculpt flex, a bio-electrical muscle stimulation apparatus engineered to support individuals across all fitness capabilities. excel V+, a versatile platform designed for addressing vascular and benign pigmented lesions. truSculpt iD, specifically tailored for the non-invasive body contouring sector. Secret RF, a fractional RF microneedling system that promotes precise tissue coagulation and hemostasis. Cutera also provides robust multi-application platforms: The enlighten platform, a laser system highly effective for tattoo removal, as well as treating benign pigmented lesions and acne scarring. The excel HR platform, offering an extensive hair removal solution compatible with diverse skin types. The xeo platform, a adaptable system where users can acquire various handpiece attachments to manage unwanted hair, treat vascular lesions, and achieve overall skin revitalization by targeting discoloration, fine lines, and laxity. In addition to its device offerings, Cutera distributes a range of skincare products and delivers post-warranty support, accessible via extended service agreements or direct billing. The company supplies specialized pulsed light handpieces for treating discoloration, facilitating hair removal, and managing vascular conditions. It further offers Pearl and Pearl Fractional handpieces, along with essential consumables such as handpiece refills, cycle refills, consumable tips, and marketing materials, all available for purchase through its official website. Cutera's products are marketed and sold through a direct sales team, reaching a wide spectrum of medical and aesthetic professionals. This includes plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, other certified practitioners, and even medical doctors performing aesthetic procedures in non-clinical environments. Founded in 1988, Cutera, Inc. maintains its corporate headquarters in Brisbane, California.

Market snapshot

Symbol
CUTR
Price
$0.10
Day change
0.00%
Market cap
$2.0M
P/E ratio
-0.01x
52-week range
0.0133-3
Sector
Healthcare
Industry
Medical - Devices
Analyst price target
$39.25

Peer companies

  • CareMax, Inc. (CMAX)
  • Fresh2 Group Limited (FRES)
  • G Medical Innovations Holdings Ltd (GMVD)
  • Vyome Holdings, Inc. (HIND)
  • Midatech Pharma plc (MTP)
  • NAYA Biosciences, Inc. (NAYA)
  • OncoSec Medical Incorporated (ONCSQ)
  • Procaps Group S.A. (PROC)

Recent insider activity

  • Patton Stephana Eilene — F-InKind (623 shares) on 2025-02-13
  • Harris Taylor C. — F-InKind (4620 shares) on 2025-02-07
  • WIERBICKI PAUL — trade (0 shares) on 2025-02-13
  • Drummond Stuart — F-InKind (22 shares) on 2025-02-01
  • Drummond Stuart — A-Award (101 shares) on 2025-01-01

Open Cutera, Inc. (CUTR) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.